Kitov Pharma Ltd. Sponsored ADR
(NASDAQ : KTOV)

( )
KTOV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.96%124.720.6%$836.51m
PFEPfizer Inc.
-0.35%37.400.9%$704.94m
MRKMerck & Co., Inc.
-0.51%62.570.6%$580.34m
ABBVAbbVie, Inc.
-0.42%96.222.1%$536.87m
BMYBristol-Myers Squibb Company
-0.79%56.411.4%$341.46m
LLYEli Lilly and Company
-0.73%89.061.0%$260.99m
NVSNovartis AG Sponsored ADR
-0.25%78.580.2%$160.01m
AZNAstraZeneca PLC Sponsored ADR
-1.37%36.651.3%$128.80m
SNYSanofi Sponsored ADR
-0.38%41.770.2%$110.26m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.70%49.530.1%$82.98m
GSKGlaxoSmithKline plc Sponsored ADR
-1.27%41.210.2%$81.16m
LCILannett Company, Inc.
-7.54%12.5837.9%$8.20m
AKTXAkari Therapeutics Plc Sponsored ADR
0.95%2.121.7%$0.25m
EPIXESSA Pharma Inc
1.29%3.940.0%$0.03m

Company Profile

Kitov Pharma Ltd. is a development stage biopharmaceutical company, which engages in drug development. The firm offers Consensi and NT219. Consensi is intended to treat osteoarthritis pain and hyper tension simultaneously, while NT219 is a cancer therapy drug that delivers anti-tumor effects and increasing survical in various cancer models. The company was founded by John Paul Waymack in June 2010 and is headquartered in Tel Aviv, Israel.